PhaseBio Pharmaceuticals Inc: 8-K filed Oct 3, 2023

Form type

8-K

Filing date

Oct 3, 2023

Accession number

0001169245-23-000052

Filer

PhaseBio Pharmaceuticals Inc (CIK 1169245)